<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ920221-0148</DOCNO><DOCID>920221-0148.</DOCID><HL>   Financing Business:   Somatix Therapy Corp.</HL><DATE>02/21/92</DATE><SO>WALL STREET JOURNAL (J), NO PAGE CITATION</SO><CO>   SOMA</CO><MS>TECHNOLOGY (TEC)</MS><IN>BIOTECHNOLOGY (BTC)MEDICAL andamp; BIOTECHNOLOGY, GENETIC RESEARCH, PROSTHETICS (MTC)STOCK AND BOND REGISTRATIONS, PRICINGS (REG)STOCK MARKET, OFFERINGS (STK)</IN><NS>BOND AND STOCK REGISTRATIONS AND PRICINGS (REG)STOCK andamp; OTHER MARKET NEWS (STK)</NS><RE>CALIFORNIA (CA)NORTH AMERICA (NME)PACIFIC RIM (PRM)UNITED STATES (US)</RE><LP>   SOMATIX THERAPY Corp., Alameda, Calif., said it completedthe public offering of three million newly issued shares ofits common stock at $11.50 each. Proceeds from the offeringwill be used for product programs in gene therapy, thecompany said. Underwriters were led by Robertson, Stephens andamp;Co., Oppenheimer andamp; Co. and Vector Securities InternationalInc.</LP><TEXT/></DOC>